MYRIAD GENETICS INC (MYGN) › Operating IncomeMYRIAD GENETICS INC (MYGN) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: $126.46M2010: $135.07M2011: $157.78M2012: $180.32M2013: $228.00M2014: $274.40M2015: $133.60M2016: $153.40M2017: $44.00M2018: $121.90M2019: $7.60M2020: -$289.70M2021: -$190.50M2022: -$140.60M2023: -$257.40M2024: -$123.50M2025: -$387.20M-$387.20M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$387.20M-213.5%2024-$123.50M+52.0%2023-$257.40M-83.1%2022-$140.60M+26.2%2021-$190.50M+34.2%2020-$289.70M-3911.8%2019$7.60M-93.8%2018$121.90M+177.0%2017$44.00M-71.3%2016$153.40M+14.8%2015$133.60M-51.3%2014$274.40M+20.4%2013$228.00M+26.4%2012$180.32M+14.3%2011$157.78M+16.8%2010$135.07M+6.8%2009$126.46M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share